Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Cancer vaccines targeting Survivin and uses thereof

Cancer vaccines targeting Survivin and uses thereof

US Patent 12064473 · Granted Aug 20, 2024

Estimated economic value: $4,439,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Vaccines for recurrent respiratory papillomatosis and methods of using the same2025
Combination therapy to treat brain cancer2025
Rotary actuated dispenser2025
Container for a stick product2025
Cosmetic product container and retention mechanism2025
Composition comprising human milk oligosaccharides for use in improving, enhanci2025
Cancer vaccines targeting MUC16 and uses thereof2025
Cancer vaccines targeting MUC16 and uses thereof2025
Cancer vaccines targeting MUC16 and uses thereof2025
Cancer vaccines targeting MUC16 and uses thereof2025
Filovirus consensus antigens, nucleic acid constructs and vaccines made therefro2025
Cancer vaccines targeting BORIS and uses thereof2024